tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

APGE Stock Latest News

Apogee Therapeutics price target raised to $115 from $100 at BTIG
The FlyApogee Therapeutics price target raised to $115 from $100 at BTIG
14d ago
APGE
3 Best Stocks to Buy Now, 7/9/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 7/9/2025, According to Top Analysts
17d ago
LLY
APGE
Promising Phase II Results for Apogee Therapeutics’ APG777 Drive Buy Rating and $89 Price Target
PremiumRatings
Promising Phase II Results for Apogee Therapeutics’ APG777 Drive Buy Rating and $89 Price Target
17d ago
APGE
Promising Potential of Apogee Therapeutics’ APG777 in Atopic Dermatitis Market Drives Buy Rating and Increased Price Target
PremiumRatings
Promising Potential of Apogee Therapeutics’ APG777 in Atopic Dermatitis Market Drives Buy Rating and Increased Price Target
18d ago
APGE
Apogee Therapeutics: Promising Phase 2 Results and Future Growth Potential Justify Buy Rating
PremiumRatings
Apogee Therapeutics: Promising Phase 2 Results and Future Growth Potential Justify Buy Rating
18d ago
APGE
Citi buyers of Apogee Therapeutics on weakness after APG777 data
PremiumThe FlyCiti buyers of Apogee Therapeutics on weakness after APG777 data
18d ago
APGE
Optimistic Buy Recommendation for Apogee Therapeutics Driven by Promising APG777 Data and Strong Financial Position
Premium
Ratings
Optimistic Buy Recommendation for Apogee Therapeutics Driven by Promising APG777 Data and Strong Financial Position
18d ago
APGE
Musk to launch new political party, Trump threatens BRICS tariff: Morning Buzz
Premium
The Fly
Musk to launch new political party, Trump threatens BRICS tariff: Morning Buzz
18d ago
SG
BUD
Morning Movers: WNS Holdings jumps following deal to be bought by Capgemini
PremiumThe Fly
Morning Movers: WNS Holdings jumps following deal to be bought by Capgemini
18d ago
CXW
GEO
Video: Tesla dips as William Blair downgrades, Musk promises new political party
PremiumThe Fly
Video: Tesla dips as William Blair downgrades, Musk promises new political party
18d ago
MGM
APGE
Apogee Therapeutics Reports Positive Phase 2 Trial Results
PremiumCompany Announcements
Apogee Therapeutics Reports Positive Phase 2 Trial Results
19d ago
8K
APGE
Apogee Therapeutics says APEX Part A met all primary, secondary endpoints
PremiumThe Fly
Apogee Therapeutics says APEX Part A met all primary, secondary endpoints
19d ago
APGE
3 Best Stocks to Buy Now, 7/3/2025, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Now, 7/3/2025, According to Top Analysts
22d ago
TTD
APGE
Buy Rating for Apogee Therapeutics: High Potential of APG777 in Atopic Dermatitis with Mitigated Risks
Premium
Ratings
Buy Rating for Apogee Therapeutics: High Potential of APG777 in Atopic Dermatitis with Mitigated Risks
1M ago
APGE
Promising Developments and Strong Market Potential Justify Buy Rating for Apogee Therapeutics
Premium
Ratings
Promising Developments and Strong Market Potential Justify Buy Rating for Apogee Therapeutics
2M ago
APGE
Buy Rating Affirmed for Apogee Therapeutics Amid Promising Trials and Strong Financial Health
PremiumRatings
Buy Rating Affirmed for Apogee Therapeutics Amid Promising Trials and Strong Financial Health
2M ago
APGE
Apogee Therapeutics Reports Q1 2025 Progress and Financials
PremiumCompany Announcements
Apogee Therapeutics Reports Q1 2025 Progress and Financials
2M ago
APGE
Apogee Therapeutics: Promising Biologics Developments Justify Buy Rating
PremiumRatings
Apogee Therapeutics: Promising Biologics Developments Justify Buy Rating
2M ago
APGE
Apogee Therapeutics Reports Positive Phase 1b Trial Results
PremiumCompany Announcements
Apogee Therapeutics Reports Positive Phase 1b Trial Results
2M ago
8K
APGE
Apogee Therapeutics reports data from Phase 1b trial of APG808
PremiumThe FlyApogee Therapeutics reports data from Phase 1b trial of APG808
2M ago
APGE
Apogee Therapeutics reports Q1 net loss ($55.3M) vs. ($32.1M) last year
Premium
The Fly
Apogee Therapeutics reports Q1 net loss ($55.3M) vs. ($32.1M) last year
2M ago
APGE
3 Best Stocks to Buy Now, 4/9/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 4/9/2025, According to Top Analysts
4M ago
APGE
GWRE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >